Primary Care Clinicians as COVID-19 Vaccine Ambassadors

J Prim Care Community Health. 2021 Jan-Dec:12:21501327211007026. doi: 10.1177/21501327211007026.

Abstract

The development of highly efficacious COVID-19 vaccines has brought a feeling of hope to many in the US (United States) and across the globe. However, it is estimated that approximately one-third of the US and international population are hesitant to receive the COVID-19 vaccine. For most Western countries with the economic means to purchase sufficient vaccine for their citizens, the medical community now has the opportunity to lead the vaccination communication campaign. Because frontline clinicians were the first to be vaccinated in the United States (US), they are uniquely positioned to be the most trusted source of vaccine information. Primary care clinicians, more than other groups of clinicians, scientists, government officials, media, etc. have the greatest chance for instilling confidence about the vaccine to their patients, including the most vulnerable and the most distrusting. They are considered credible and trustworthy allies for their patients in the US, however, clinicians receive little to no formal training in communication related to controversial topics, such as vaccine hesitancy. With the increasing worry about highly transmissible COVID-19 viral mutations and possible related vaccine resistance, it becomes even more critical to accelerate vaccination efforts across every community. Educating primary care clinicians regarding the importance of talking to their patients regarding their COVID-19 vaccination plans is essential.

Keywords: community health; disease management; global health; health outcomes; prevention; primary care; public health; quality improvement; underserved communities; vaccine hesitancy.

MeSH terms

  • COVID-19 / prevention & control*
  • COVID-19 Vaccines / therapeutic use*
  • Health Communication / methods*
  • Humans
  • Patient Education as Topic / methods*
  • Physicians, Primary Care / education*
  • SARS-CoV-2
  • United States
  • Vaccination Refusal

Substances

  • COVID-19 Vaccines